Found 358 matching trials
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial PHASE3 RATIONALE: Providing information that is tailored to answer patients' quest...
Show More Location
Barbara Ann Karmanos Cancer Institute
Learn More & Join Trial
Autologous Polyclonal Tregs for Lupus PHASE1 The primary purpose of this Phase 1 study is to evaluate the safety, tolera...
Show More Location
University of California, San Francisco
Learn More & Join Trial
REACT-01: Reversing Autoimmunity Through Cell Therapy PHASE1 This is a phase 1, open-label, non-randomized study enrolling pediatric and...
Show More Location
Seattle Children's Hospital
Learn More & Join Trial
PSMA-RLT in Biochemically Recurrent PCa PHASE2 Prospective single-center one-arm phase II study in patients with prostate ...
Show More Location
Medical University of Vienna
Learn More & Join Trial
Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases PHASE1 The CATARSIS study explores the use of anti-CD19 CAR T-cell therapy as a no...
Show More Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Learn More & Join Trial
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease PHASE1 CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B cell mediated...
Show More Location
Children's Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant PHASE2 RATIONALE: Antifungals, such as caspofungin acetate, may be effective in tr...
Show More Location
CHU Liege - Domaine Universitaire du Sart Tilman
Learn More & Join Trial
Romidepsin Maintenance After Allogeneic Stem Cell Transplantation PHASE1 The goal of this clinical research study is to learn if giving romidepsin b...
Show More Location
The Ohio State University Cancer Center
Learn More & Join Trial
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer PHASE3 This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Show More Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Learn More & Join Trial
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease PHASE1 This is a first-in-human, single-arm, open-label study evaluating the safet...
Show More Learn More & Join Trial